Because measurements of body indices are relatively inexpensive and simple in a clinical setting, using the most suitable anthropometric measurement to identify individuals at high risk of elevated ALT and hepatic diseases who may benefit from early intervention has important public health implications for better prevention, diagnosis, and treatment. This evidence concerns the gene GPT and liver disorder.